Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
PJT Partners
PJT
$4.3B
| $612K | ﹤0.01% |
8,302
-658
| -7% | -$49.3K |
|
1602
Repligen
RGEN
$7.96B
| $612K | ﹤0.01% |
3,613
-45,405
| -93% | -$8.24M |
|
1603
Plug Power
PLUG
$2.87B
| $610K | ﹤0.01% |
49,359
-49,371
| -50% | -$786K |
|
1604
Invesco
IVZ
$13.1B
| $610K | ﹤0.01% |
33,928
-33,934
| -50% | -$580K |
|
|
POW
1605
DELISTED
Powered Brands Class A Ordinary Shares
POW
| $610K | ﹤0.01% |
+60,321
| New | +$605K |
|
1606
NMI Holdings
NMIH
$3.33B
| $609K | ﹤0.01% |
29,162
-34,322
| -54% | -$719K |
|
|
ARYD
1607
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $609K | ﹤0.01% |
60,274
-60,274
| -50% | -$604K |
|
1608
Pentair
PNR
$10.4B
| $609K | ﹤0.01% |
13,535
-19,937
| -60% | -$867K |
|
|
TGVC
1609
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
| $608K | ﹤0.01% |
59,676
-59,676
| -50% | -$601K |
|
|
AYX
1610
DELISTED
Alteryx Inc
AYX
| $607K | ﹤0.01% |
11,972
-11,972
| -50% | -$571K |
|
1611
CAE Inc. Common Shares
CAE
$8.3B
| $606K | ﹤0.01% |
31,340
-31,340
| -50% | -$602K |
|
1612
Douglas Emmett
DEI
$1.98B
| $605K | ﹤0.01% |
38,610
-24,614
| -39% | -$410K |
|
1613
Hecla Mining
HL
$9.47B
| $605K | ﹤0.01% |
108,689
-108,691
| -50% | -$540K |
|
1614
Radian Group
RDN
$5.18B
| $604K | ﹤0.01% |
31,653
-31,659
| -50% | -$616K |
|
1615
Peabody Energy
BTU
$2.6B
| $602K | ﹤0.01% |
22,785
-18,787
| -45% | -$516K |
|
|
OHAA
1616
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
| $601K | ﹤0.01% |
60,167
-60,167
| -50% | -$602K |
|
1617
Spire
SR
$4.72B
| $600K | ﹤0.01% |
8,718
+1,600
| +22% | +$109K |
|
1618
Ultragenyx Pharmaceutical
RARE
$2.45B
| $599K | ﹤0.01% |
12,931
-12,929
| -50% | -$509K |
|
|
SLAC
1619
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
| $596K | ﹤0.01% |
59,741
-60,181
| -50% | -$599K |
|
1620
RXO
RXO
$3.34B
| $594K | ﹤0.01% |
+34,557
| New | +$613K |
|
|
FCAX
1621
DELISTED
Fortress Capital Acquisition Corp.
FCAX
| $594K | ﹤0.01% |
+58,707
| New | +$589K |
|
1622
Chegg
CHGG
$110M
| $593K | ﹤0.01% |
23,480
-23,482
| -50% | -$597K |
|
1623
Columbia Sportswear
COLM
$3.04B
| $590K | ﹤0.01% |
6,743
+1
| +0% | +$80 |
|
1624
Roku
ROKU
$21.5B
| $590K | ﹤0.01% |
14,500
-14,502
| -50% | -$758K |
|
1625
Goodyear
GT
$2B
| $586K | ﹤0.01% |
57,806
-40,410
| -41% | -$441K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.